HOLX Valuation

Hologic Inc

Add to Watchlist

Advanced Chart

67.170

-1.59(-2.312%)1D

Overview
Forecast
Valuation
Earnings

HOLX Relative Valuation

HOLX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HOLX is overvalued; if below, it's undervalued.

Historical Valuation

Hologic Inc (HOLX) is now in the Undervalued zone, suggesting that its current forward PE ratio of 15.32 is considered Undervalued compared with the five-year average of 17.34. The fair price of Hologic Inc (HOLX) is between 69.08 to 97.06 according to relative valuation methord. Compared to the current price of 68.76 USD , Hologic Inc is Undervalued By 0.46%.

Relative Value

Fair Zone

69.08-97.06

Current Price：68.76

0.46%

Undervalued

15.54

Trailing

Forward

11.52

EV/EBITDA

Hologic Inc. (HOLX) has a current EV/EBITDA of 11.52. The 5-year average EV/EBITDA is 12.82. The thresholds are as follows: Strongly Undervalued below 7.93, Undervalued between 7.93 and 10.37, Fairly Valued between 15.26 and 10.37, Overvalued between 15.26 and 17.70, and Strongly Overvalued above 17.70. The current Forward EV/EBITDA of 11.52 falls within the Historic Trend Line -Fairly Valued range.

12.37

EV/EBIT

Hologic Inc. (HOLX) has a current EV/EBIT of 12.37. The 5-year average EV/EBIT is 13.74. The thresholds are as follows: Strongly Undervalued below 8.25, Undervalued between 8.25 and 11.00, Fairly Valued between 16.49 and 11.00, Overvalued between 16.49 and 19.23, and Strongly Overvalued above 19.23. The current Forward EV/EBIT of 12.37 falls within the Historic Trend Line -Fairly Valued range.

3.63

Hologic Inc. (HOLX) has a current PS of 3.63. The 5-year average PS is 4.26. The thresholds are as follows: Strongly Undervalued below 3.16, Undervalued between 3.16 and 3.71, Fairly Valued between 4.81 and 3.71, Overvalued between 4.81 and 5.36, and Strongly Overvalued above 5.36. The current Forward PS of 3.63 falls within the Undervalued range.

14.33

P/OCF

Hologic Inc. (HOLX) has a current P/OCF of 14.33. The 5-year average P/OCF is 13.59. The thresholds are as follows: Strongly Undervalued below 7.59, Undervalued between 7.59 and 10.59, Fairly Valued between 16.59 and 10.59, Overvalued between 16.59 and 19.59, and Strongly Overvalued above 19.59. The current Forward P/OCF of 14.33 falls within the Historic Trend Line -Fairly Valued range.

14.98

P/FCF

Hologic Inc. (HOLX) has a current P/FCF of 14.98. The 5-year average P/FCF is 14.50. The thresholds are as follows: Strongly Undervalued below 7.76, Undervalued between 7.76 and 11.13, Fairly Valued between 17.87 and 11.13, Overvalued between 17.87 and 21.25, and Strongly Overvalued above 21.25. The current Forward P/FCF of 14.98 falls within the Historic Trend Line -Fairly Valued range.

Hologic Inc (HOLX) has a current Price-to-Book (P/B) ratio of 3.11. Compared to its 3-year average P/B ratio of 3.51 , the current P/B ratio is approximately -11.45% higher. Relative to its 5-year average P/B ratio of 4.08, the current P/B ratio is about -23.71% higher. Hologic Inc (HOLX) has a Forward Free Cash Flow (FCF) yield of approximately 6.23%. Compared to its 3-year average FCF yield of 6.72%, the current FCF yield is approximately -7.32% lower. Relative to its 5-year average FCF yield of 7.94% , the current FCF yield is about -21.51% lower.

3.16

P/B

Median3y

3.51

Median5y

4.08

6.09

FCF Yield

Median3y

6.72

Median5y

7.94

Competitors Valuation Multiple

The average P/S ratio for HOLX's competitors is 3.82, providing a benchmark for relative valuation. Hologic Inc Corp (HOLX) exhibits a P/S ratio of 3.63, which is -5.07% above the industry average. Given its robust revenue growth of 1.23%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

West Pharmaceutical Services Inc

Baxter International Inc

1.08

4.31%

12.25B

Performance Decomposition

Market capitalization of HOLX decreased by 17.32% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 1.01B to 1.02B.

The secondary factor is the Margin Expansion, contributed -0.99%to the performance.

Overall, the performance of HOLX in the past 1 year is driven by Revenue Growth. Which is more sustainable.

1.23%

1.01B → 1.02B

Revenue Growth

-0.99%

19.23 → 19.04

Margin Expansion

-17.56%

34.55 → 28.48

P/E Change

-17.32%